Shanghai OPM Biosciences Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 171.69 million compared to CNY 223.11 million a year ago. Revenue was CNY 171.69 million compared to CNY 223.11 million a year ago.

Net income was CNY 43.18 million compared to CNY 83.09 million a year ago. Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.9286 a year ago. Diluted earnings per share from continuing operations was CNY 0.38 compared to CNY 0.9286 a year ago.